Intervention Review

Pneumococcal vaccines for sickle cell disease

  1. E Graham Davies1,*,
  2. Ceri Hirst2,
  3. Richard Lottenberg3,
  4. Nancy Dower4

Editorial Group: Cochrane Cystic Fibrosis and Genetic Disorders Group

Published Online: 16 JUN 2010

Assessed as up-to-date: 9 DEC 2011

DOI: 10.1002/14651858.CD003885.pub2

Database Title

Additional Information

How to Cite

Davies EG, Hirst C, Lottenberg R, Dower N. Pneumococcal vaccines for sickle cell disease. Cochrane Database of Systematic Reviews 2004, Issue 1. Art. No.: CD003885. DOI: 10.1002/14651858.CD003885.pub2.

Author Information

  1. 1

    Great Ormond Street Hospital, Host Defence Unit, London, UK

  2. 2

    AstraZeneca, Alderley Park, Cheshire, UK

  3. 3

    University of Florida College of Medicine, Division of Hematology/Oncology, Florida, USA

  4. 4

    Faculty of Medicine, Department of Pediatrics, Edmonton, Alberta, Canada

*E Graham Davies, Host Defence Unit, Great Ormond Street Hospital, Great Ormond Street, London, WC1N 3JH, UK. davieg1@gosh.nhs.uk.

Publication History

  1. Publication Status: Stable (no update expected for reasons given in 'What's new')
  2. Published Online: 16 JUN 2010

SEARCH

ARTICLE TOOLS

View Full Article (HTML) Summary (58K)Standard (329K)Full (406K)

  1. Current Version

    Pneumococcal vaccines for sickle cell disease

    E Graham Davies, Ceri Hirst, Richard Lottenberg and Nancy Dower

    Article first published online: 16 JUN 2010 | DOI: 10.1002/14651858.CD003885.pub2

Previous versions of this article and their online publication dates

  1. Version 1

    Pneumococcal vaccines for sickle cell disease

    EG Davies, R Lottenberg and N Dower

    Article first published online: 27 JUN 2002 | DOI: 10.1002/14651858.CD003885

View Full Article (HTML) Summary (58K)Standard (329K)Full (406K)